These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28741788)

  • 21. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
    Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
    Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sample Preparation Methods Following CellSearch Approach Compatible of Single-Cell Whole-Genome Amplification: An Overview.
    Swennenhuis JF; Terstappen L
    Methods Mol Biol; 2015; 1347():57-67. PubMed ID: 26374309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients.
    Mostert B; Sieuwerts AM; Bolt-de Vries J; Kraan J; Lalmahomed Z; van Galen A; van der Spoel P; de Weerd V; Ramírez-Moreno R; Smid M; Verhoef C; IJzermans JN; Gratama JW; Sleijfer S; Foekens JA; Martens JW
    Mol Oncol; 2015 Apr; 9(4):920-32. PubMed ID: 25655581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter.
    Watanabe M; Kenmotsu H; Ko R; Wakuda K; Ono A; Imai H; Taira T; Naito T; Murakami H; Abe M; Endo M; Nakajima T; Koh Y; Takahashi T
    Cancer Sci; 2018 Aug; 109(8):2539-2548. PubMed ID: 29900633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients.
    Huebner H; Fasching PA; Gumbrecht W; Jud S; Rauh C; Matzas M; Paulicka P; Friedrich K; Lux MP; Volz B; Gass P; Häberle L; Meier-Stiegen F; Hartkopf A; Neubauer H; Almstedt K; Beckmann MW; Fehm TN; Ruebner M
    BMC Cancer; 2018 Feb; 18(1):204. PubMed ID: 29463222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of the Clinical Utility of Circulating Tumor Cells at Different Time Points in Predicting Prognosis of Patients With Small Cell Lung Cancer: A Meta-Analysis.
    Jiang AM; Zheng HR; Liu N; Zhao R; Ma YY; Bai SH; Tian T; Liang X; Ruan ZP; Fu X; Yao Y
    Cancer Control; 2021; 28():10732748211050581. PubMed ID: 34654345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancer.
    Normanno N; Rossi A; Morabito A; Signoriello S; Bevilacqua S; Di Maio M; Costanzo R; De Luca A; Montanino A; Gridelli C; Rocco G; Perrone F; Gallo C
    Lung Cancer; 2014 Aug; 85(2):314-9. PubMed ID: 24882383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RareCyte® CTC Analysis Step 1: AccuCyte® Sample Preparation for the Comprehensive Recovery of Nucleated Cells from Whole Blood.
    Ramirez AB; U'Ren L; Campton DE; Stewart D; Nordberg JJ; Stilwell JL; Kaldjian EP
    Methods Mol Biol; 2017; 1634():163-172. PubMed ID: 28819849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy.
    Onstenk W; Kraan J; Mostert B; Timmermans MM; Charehbili A; Smit VT; Kroep JR; Nortier JW; van de Ven S; Heijns JB; Kessels LW; van Laarhoven HW; Bos MM; van de Velde CJ; Gratama JW; Sieuwerts AM; Martens JW; Foekens JA; Sleijfer S
    Mol Cancer Ther; 2015 Mar; 14(3):821-7. PubMed ID: 25552367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of CellSearch and Circulating Tumor Cells (CTC)-Biopsy Systems in Detecting Peripheral Blood Circulating Tumor Cells in Patients with Gastric Cancer.
    Ning D; Cui K; Liu M; Ou Y; Wang Z; Zou B; Shen Y; Lu X; Li S; Li P
    Med Sci Monit; 2021 Jan; 27():e926565. PubMed ID: 33408319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enumeration, Dielectrophoretic Capture, and Molecular Analysis of Circulating Tumor Cells.
    Yee SS; Carpenter EL
    Methods Mol Biol; 2017; 1634():193-202. PubMed ID: 28819852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving the CellSearch® system.
    Swennenhuis JF; van Dalum G; Zeune LL; Terstappen LW
    Expert Rev Mol Diagn; 2016 Dec; 16(12):1291-1305. PubMed ID: 27797592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer.
    Messaritakis I; Politaki E; Kotsakis A; Dermitzaki EK; Koinis F; Lagoudaki E; Koutsopoulos A; Kallergi G; Souglakos J; Georgoulias V
    PLoS One; 2017; 12(7):e0181211. PubMed ID: 28719656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fourier Ptychographic Microscopy for Rapid, High-Resolution Imaging of Circulating Tumor Cells Enriched by Microfiltration.
    Williams A; Chung J; Yang C; Cote RJ
    Methods Mol Biol; 2017; 1634():107-117. PubMed ID: 28819844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a Protocol for Single-Cell Analysis of Circulating Tumor Cells in Patients with Solid Tumors.
    Reduzzi C; Motta R; Bertolini G; Miodini P; Martinetti A; Sottotetti E; Daidone MG; Cappelletti V
    Adv Exp Med Biol; 2017; 994():83-103. PubMed ID: 28560669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catch and Release: rare cell analysis from a functionalised medical wire.
    Chen S; El-Heliebi A; Tauber G; Langsenlehner T; Pötscher M; Kashofer K; Czyż ZT; Polzer B; Riethdorf S; Kuske A; Leitinger G; Pantel K; Kroneis T; Sedlmayr P
    Sci Rep; 2017 Feb; 7():43424. PubMed ID: 28233867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanostructure embedded microchips for detection, isolation, and characterization of circulating tumor cells.
    Lin M; Chen JF; Lu YT; Zhang Y; Song J; Hou S; Ke Z; Tseng HR
    Acc Chem Res; 2014 Oct; 47(10):2941-50. PubMed ID: 25111636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viable circulating tumour cell detection using multiplex RNA in situ hybridisation predicts progression-free survival in metastatic breast cancer patients.
    Payne RE; Wang F; Su N; Krell J; Zebrowski A; Yagüe E; Ma XJ; Luo Y; Coombes RC
    Br J Cancer; 2012 May; 106(11):1790-7. PubMed ID: 22538972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic changes of phenotypically different circulating tumor cells sub-populations in patients with recurrent/refractory small cell lung cancer treated with pazopanib.
    Messaritakis I; Politaki E; Koinis F; Stoltidis D; Apostolaki S; Plataki M; Dermitzaki EK; Georgoulias V; Kotsakis A
    Sci Rep; 2018 Feb; 8(1):2238. PubMed ID: 29396560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of label-free technologies in head and neck cancer circulating tumour cells.
    Kulasinghe A; Kenny L; Perry C; Thiery JP; Jovanovic L; Vela I; Nelson C; Punyadeera C
    Oncotarget; 2016 Nov; 7(44):71223-71234. PubMed ID: 27655722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.